TFA
EDIT icon

Toth Financial Advisory’s Editas Medicine EDIT Stock Holding History

Toth Financial Advisory’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-250
Closed -$853 – 716
2024
Q3 		$853 Hold
250
– – ﹤0.01% 676
2024
Q2 		$1.17K Buy
+250
New +$1.41K ﹤0.01% 682
2022
Q2 		– Sell
-100
Closed -$2K – 717
2022
Q1 		$2K Hold
100
– – ﹤0.01% 615
2021
Q4 		$3K Hold
100
– – ﹤0.01% 605
2021
Q3 		$4K Sell
100
-100
-50% -$5.48K ﹤0.01% 574
2021
Q2 		$11K Hold
200
– – ﹤0.01% 446
2021
Q1 		$8K Hold
200
– – ﹤0.01% 481
2020
Q4 		$14K Hold
200
– – ﹤0.01% 377
2020
Q3 		$6K Buy
200
+100
+100% +$3.26K ﹤0.01% 410
2020
Q2 		$3K Hold
100
– – ﹤0.01% 442
2020
Q1 		$2K Hold
100
– – ﹤0.01% 386
2019
Q4 		$3K Buy
100
+20
+25% +$499 ﹤0.01% 388
2019
Q3 		$2K Buy
+80
New +$1.98K ﹤0.01% 404

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Toth Financial Advisory's EDIT Position: Q4 2024 in Review

Toth Financial Advisory sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 250 shares — an estimated $853 sold.

Toth Financial Advisory first reported a position in EDIT in Q3 2019 and held it in 13 quarters. The position peaked at $14K in Q4 2020. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Toth Financial Advisory reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Toth Financial Advisory sold 250 Editas Medicine shares in Q4 2024, an estimated $853.
  • Toth Financial Advisory first reported a position in Editas Medicine in Q3 2019 and held it in 13 quarters.
  • Toth Financial Advisory's Editas Medicine position peaked at $14K in Q4 2020.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Toth Financial Advisory's 13F filing for Q4 2024, filed 21 Jan 2025.